Gordon Naylor
Gordon Naylor is the interim chief executive of CSL, an Australian biotechnology firm, who stepped into the role amid significant challenges for the company, including a $1.5 billion writedown and a sharp decline in share value attributed to regulatory changes and declining vaccination rates in the US.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Gordon Naylor is the interim boss of CSL following the retirement of Paul McKenzie.
5
Australia:
CSL’s interim chief executive, Gordon Naylor, said on Wednesday that his appointment will not be a passive one.
6